The company is headquartered in Hangzhou, Zhejiang, China. For a complete picture of SY-001’s drug-specific PTSR and LoA scores, buy the report here. Blending expert knowledge with cutting-edge ...
Heartseed Inc. and Novo Nordisk - in partnership since June 2021 - have announced that the first patient has been successfully dosed in a clinical study with HS-001, a cell therapy designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback